EIF3F p.Phe232Val
c.694T>G · rs141976414 · VCV617475
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9997 | likely pathogenic ✓ concordant with ClinVar · top 6% in EIF3F |
|---|---|---|
| REVEL | 0.759 | pathogenic-leaning |
| SaProt | LLR -12.47 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 0.76, phastCons 1 |
| Regional constraint | o/e 0.75 | unconstrained · MANE · 8,406 bp · p 4.6e-06 · regional, not allelic |
| Overall | ||
| CADD | 28.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.182% | 548 |
| European (non-Finnish)grpmax | 0.157% | 636 |
| Remaining individualsnot grpmax-eligible | 0.107% | 933 |
| Admixed American | 0.0367% | 2,728 |
| African / African-American | 0.0227% | 4,414 |
| South Asian | 0.00439% | 22,762 |
| Finnishnot grpmax-eligible | 0.00312% | 32,014 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EIF3F
- Protein
- p.Phe232Val
- Coding
- c.694T>G
- MANE Select
- NM_003754
- dbSNP
- rs141976414
- Type
- single nucleotide variant
- Location
- chr11:7994466 (GRCh38)
- Gene constraint
- LOEUF 0.46 · pLI 0.99 (gnomAD)
- Structure
- AlphaFold pLDDT 75.97 · 29 PDB
- Residue 232
- a UniProt-annotated variant site (in mrt67; decreased protein abundance); a β-strand
Disease context
neurodevelopmental disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: intellectual disabilityintellectual developmental disorder, autosomal recessive 67neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
Similar variants
- EIF3F p.Arg306Cys Uncertain significance ★★ ⚠ same condition
- EIF3F p.Thr14Met Uncertain significance ★★ ⚠ same condition
- EIF3F p.Thr303Ile Uncertain significance ★★ ⚠ same condition
- EIF3F c.*24C>T Benign ★★ same condition
- EIF3F p.His187= Benign ★★ same condition
- EIF3F c.653+3G>T Uncertain significance ★ same condition
- EIF3F p.Asn342Ser Uncertain significance ★ ⚠ same condition
- EIF3F p.Gly88Asp Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eif3f-p-phe232val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown